This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why Investing in Markel (MKL) is a Prudent Move Now
by Zacks Equity Research
Markel (MKL) stands to benefit from rate increases across professional liability and general liability product lines, strong capital position, and effective capital deployment.
Markel (MKL) Expands in France, Opens New Branch Office
by Zacks Equity Research
Markel (MKL) has opened branch office in Paris to expand in global key specialty insurance markets.
Is Markel Corporation (MKL) Stock a Solid Choice Right Now?
by Zacks Equity Research
Markel Corporation (MKL) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
The Zacks Analyst Blog Highlights: Continental Resources, Devon Energy, Ulta Beauty, Markel Corp and HP
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Continental Resources, Devon Energy, Ulta Beauty, Markel Corp and HP
Top 5 High-Flying Stocks With Strong Momentum for September
by Nalak Das
We have narrowed down our search to five large-cap momentum stocks that have provided more than 20% returns year to date. These are: ULTA, DVN, HPQ, MKL and CLR.
Why Is Markel (MKL) Up 4.9% Since Last Earnings Report?
by Zacks Equity Research
Markel (MKL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Markel (MKL) Q2 Earnings and Revenues Top Estimates, Rise Y/Y
by Zacks Equity Research
Markel (MKL) Q2 results reflect double-digit premium growth in underwriting operations through both organic growth in new businesses and more favorable rates.
Markel (MKL) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Markel (MKL) delivered earnings and revenue surprises of 23.88% and 11.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Markel (MKL) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
Markel (MKL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Consider Markel (MKL) Stock Now?
by Zacks Equity Research
Let's see if Markel (MKL) stock is a good choice for value-oriented investors right now from multiple angles.
Here's Why Markel (MKL) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Is Markel (MKL) Up 5.1% Since Last Earnings Report?
by Zacks Equity Research
Markel (MKL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Markel (MKL) Q1 Earnings and Revenues Miss Estimates, Up Y/Y
by Zacks Equity Research
Markel (MKL) Q1 results reflect growth across underwriting operations, focus on increasing operational efficiencies, strong performance at Markel Ventures as well as positive momentum in investment operations.
Markel (MKL) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Markel (MKL) delivered earnings and revenue surprises of -10.99% and -3.32%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Hanover Insurance (THG) Up 46% in a Year: More Room to Run?
by Zacks Equity Research
Prudent management of business mix, focus on growth of the most profitable product lines, stable retention, better pricing, strong market presence and effective capital management continue to drive Hanover Insurance's performance.
Palomar (PLMR) Shares Up on New $40M Share Buyback Program
by Zacks Equity Research
Palomar Holdings' (PLMR) new share repurchase program reflects effective capital deployment backed by a solid financial position, thanks to strong core operations.
Reasons Why Markel (MKL) Stock is an Attractive Bet Now
by Zacks Equity Research
Riding high on improved results of its businesses, strategic acquisitions and sufficient liquidity, Markel (MKL) has potential to reward its investors.
Why You Should Hold Cboe Global (CBOE) in Your Portfolio
by Zacks Equity Research
Cboe Global Markets' (CBOE) expanding product line across asset classes, geographic reach, diversifying business mix and solid liquidity make its worthy of retention in one's portfolio.
Fidelity National (FNF) Up 84% in a Year: Will the Rally Last?
by Zacks Equity Research
Leading market share in the residential purchase, refinance, and commercial markets, efforts to diversify from core title insurance business, industry-leading margins, and solid capital position continue to drive Fidelity National (FNF).
Progressive's (PGR) February Earnings Up as Revenues Rise Y/Y
by Zacks Equity Research
Progressive's (PGR) February results reflect increase in premiums, fee income and service revenues, partially offset by increase in expenses.
New Strong Buy Stocks for March 12th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.
Why You Should Hold NMI Holdings (NMIH) Stock in Portfolio
by Zacks Equity Research
NMI Holdings' (NMIH) growth on new primary insurance written, direct primary insurance in force and an improving risk-based capital ratio make its worthy of retention in one's portfolio.
W. R. Berkley (WRB) Prices 3.550% $400 Senior Unsecured Notes
by Zacks Equity Research
W. R. Berkley (WRB) displays prudence by issuing senior notes amid a low interest rate environment to procure funds.
Assurant (AIZ) to Divest Global Preneed for $1.3 Billion Cash
by Zacks Equity Research
Assurant's (AIZ) divestiture of Global Preneed is a strategic step toward intensifying focus on market-leading lifestyle and housing businesses.
New Strong Buy Stocks for March 9th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.